Company Filing History:
1 out of 2,405 
1 out of 2 Years Active: 2023
Title: The Innovative Contributions of Haiheng Guo
Introduction
Haiheng Guo is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His work has led to advancements in synthetic pathways that are crucial for creating effective medications.
Latest Patents
Haiheng Guo holds a patent for a synthetic pathway to belzutifan and crystalline phases of synthetic intermediates. This patent provides crystalline forms for certain synthetic intermediates used in the production of belzutifan, a HIF-2α inhibitor that is beneficial for cancer treatment. The patent also outlines processes for isolating these crystalline forms, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Guo has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH, where he has contributed to various research and development projects. His expertise in synthetic chemistry has been instrumental in advancing therapeutic options for patients.
Collaborations
Some of his notable coworkers include Stephen M. Dalby and Clinton Scott Shultz. Their collaborative efforts have further enhanced the research and development initiatives within the companies they have worked for.
Conclusion
Haiheng Guo's innovative work in the pharmaceutical industry, particularly in the development of synthetic pathways for cancer treatment, highlights his significant contributions to medical science. His patent and collaborations reflect a commitment to advancing healthcare solutions.